Differential culture medium of human pluripotent stem cell derived mesoderm cells and application of differential culture medium
A technology of human pluripotent stem cells and differentiation medium, which is applied in the field of cell differentiation culture, can solve the problems of low differentiation efficiency, low grade of raw materials, and high cost, and achieve the effects of high differentiation efficiency, clear components, and high universality
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0087] Example 1 Differentiation medium for mesoderm cells derived from human pluripotent stem cells
[0088] A differentiation medium for human pluripotent stem cell-derived mesoderm cells, the differentiation medium consists of the following components:
[0089] Basal medium: RPMI1640 medium (1×);
[0090] Compound combination: the components and final use concentrations of the compound combination are: D-pipercolic acid 300 μg / L, triiodo-L-thyronine 800 μg / L and thiamine hydrochloride 45 mg / L;
[0091] GSK-3 inhibitor: the GSK-3 inhibitor and the final use concentration are CHIR99021 8 μM.
Embodiment 2
[0092] Example 2 Differentiation medium for mesoderm cells derived from human pluripotent stem cells
[0093] A differentiation medium for human pluripotent stem cell-derived mesoderm cells, the differentiation medium consists of the following components:
[0094] Basal medium: DMEM / F12 medium (1×);
[0095] Compound combination: the components and final use concentrations of the compound combination are: D-pipercolic acid 300 μg / L, triiodo-L-thyronine 800 μg / L and thiamine hydrochloride 45 mg / L;
[0096] GSK-3 inhibitor: the GSK-3 inhibitor and the final use concentration are CHIR99021 8 μM.
Embodiment 3
[0097] Example 3 Differentiation medium for human pluripotent stem cell-derived mesoderm cells
[0098] A differentiation medium for human pluripotent stem cell-derived mesoderm cells, the differentiation medium consists of the following components:
[0099] Basal medium: IMDM medium (1×);
[0100] Compound combination: the components and final use concentrations of the compound combination are: D-pipercolic acid 300 μg / L, triiodo-L-thyronine 800 μg / L and thiamine hydrochloride 45 mg / L;
[0101] GSK-3 inhibitor: the GSK-3 inhibitor and the final use concentration are CHIR99021 8 μM.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com